Kistler-Tiffany Companies’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Kistler-Tiffany Companies’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-690	Closed	–	–	649
2020 Q1	$0	Hold	690	–	–	﹤0.01%	575
2019 Q4	$0	Hold	690	–	–	﹤0.01%	602
2019 Q3	$0	Hold	690	–	–	﹤0.01%	608
2019 Q2	$0	Hold	690	–	–	﹤0.01%	598
2019 Q1	$0	Hold	690	–	–	﹤0.01%	588
2018 Q4	$0	Hold	690	–	–	﹤0.01%	585
2018 Q3	$1K	Hold	690	–	–	﹤0.01%	552
2018 Q2	$1K	Hold	690	–	–	﹤0.01%	560
2018 Q1	$1K	Hold	690	–	–	﹤0.01%	550
2017 Q4	$1K	Hold	690	–	–	﹤0.01%	548
2017 Q3	$1K	Hold	690	–	–	﹤0.01%	541
2017 Q2	$1K	Hold	690	–	–	﹤0.01%	500
2017 Q1	$1K	Hold	690	–	–	﹤0.01%	500
2016 Q4	$4K	Hold	690	–	–	﹤0.01%	463
2016 Q3	$4K	Hold	690	–	–	﹤0.01%	489
2016 Q2	$4K	Sell	690 -402	-37%	-$2.11K	﹤0.01%	499
2016 Q1	$5K	Hold	1,092	–	–	﹤0.01%	468
2015 Q4	$7K	Buy	+1,092	New	+$7.41K	﹤0.01%	476

Kistler-Tiffany Companies's GNMX Position: Q2 2020 in Review

Kistler-Tiffany Companies sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2020, closing a stake of 690 shares.

Kistler-Tiffany Companies first reported a position in GNMX in Q4 2015 and held it in 18 quarters. The position peaked at $7K in Q4 2015. 0 funds tracked by Wall St. Rank hold GNMX as of Q2 2020.

Kistler-Tiffany Companies reported no remaining Aevi Genomic Medicine Inc position as of Q2 2020 after selling out during the quarter.
Kistler-Tiffany Companies sold 690 Aevi Genomic Medicine Inc shares in Q2 2020.
Kistler-Tiffany Companies first reported a position in Aevi Genomic Medicine Inc in Q4 2015 and held it in 18 quarters.
Kistler-Tiffany Companies's Aevi Genomic Medicine Inc position peaked at $7K in Q4 2015.
0 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2020.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2020, filed 20 Jul 2020.